Gyeong-Ho Lee
Director/Board Member chez DUCHEMBIO CO.,LTD.
Profil
Gyeong-Ho Lee is an Independent Director at DuChemBIO Co., Ltd.
and a Member of the National Bioethics Committee.
He previously served as an Independent Director at FCB Twelve Co., Ltd.
from 2010 to 2011 and at Pharmicell Co., Ltd.
He was also the Chancellor at Inje University from 2007 to 2010.
Lee is a graduate of Seoul National University.
Postes actifs de Gyeong-Ho Lee
Sociétés | Poste | Début |
---|---|---|
DUCHEMBIO CO.,LTD. | Director/Board Member | 29/03/2022 |
National Bioethics Committee | Corporate Officer/Principal | 19/11/2010 |
Anciens postes connus de Gyeong-Ho Lee
Sociétés | Poste | Fin |
---|---|---|
FCB Twelve Co., Ltd.
FCB Twelve Co., Ltd. Apparel/FootwearConsumer Non-Durables FCB Twelve Co., Ltd. is engaged in manufacturing, distributing, and selling cell therapeutic drugs and apparels. It operates in two segments: Biotechnology and Fashion. The Biotechnology Segment offers stem cell therapeutic drugs, adult stem cell banking service, and stem cell skin care solution. The Fashion Segment offers garments and other fashion accessories under three brands such as basic by GV2, studio yume, and le body lingerie. It also provides hospital management consulting, resort amenities and services, as well as technology transfer. The company was founded on August 20, 1968 and is headquartered in Seoul, South Korea. | Director/Board Member | 06/10/2011 |
Inje University | Corporate Officer/Principal | 01/08/2010 |
PHARMICELL CO., LTD. | Director/Board Member | - |
Formation de Gyeong-Ho Lee
Seoul National University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
PHARMICELL CO., LTD. | Health Technology |
DUCHEMBIO CO.,LTD. | Health Technology |
Entreprise privées | 2 |
---|---|
FCB Twelve Co., Ltd.
FCB Twelve Co., Ltd. Apparel/FootwearConsumer Non-Durables FCB Twelve Co., Ltd. is engaged in manufacturing, distributing, and selling cell therapeutic drugs and apparels. It operates in two segments: Biotechnology and Fashion. The Biotechnology Segment offers stem cell therapeutic drugs, adult stem cell banking service, and stem cell skin care solution. The Fashion Segment offers garments and other fashion accessories under three brands such as basic by GV2, studio yume, and le body lingerie. It also provides hospital management consulting, resort amenities and services, as well as technology transfer. The company was founded on August 20, 1968 and is headquartered in Seoul, South Korea. | Consumer Non-Durables |
National Bioethics Committee |